Permanently Discontinued

GLN-TOPIRAMATE

GLENMARK PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is GLN-TOPIRAMATE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that GLN-TOPIRAMATE 200MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is GLN-TOPIRAMATE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 5 same form & route

Affected strength200MG

Report last updated2026-10-27

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TEVA-TOPIRAMATE

TEVA CANADA LIMITED

200MG · DIN 02248862

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TOPAMAX

JANSSEN INC

15MG · DIN 02239907

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PMS-TOPIRAMATE

PHARMASCIENCE INC

25MG · DIN 02262991

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-TOPIRAMATE

PRO DOC LIMITEE

25MG · DIN 02313650

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-TOPIRAMATE

APOTEX INC

25MG · DIN 02279614

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-TOPIRAMATE

AURO PHARMA INC

100MG · DIN 02345838

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02287781

Strength

200MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

TOPIRAMATE

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

GLN-TOPIRAMATE has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-19

Resolved

Disruption of the manufacture of the drug.

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-ATOVAQUONE

750MG · DIN 02528495